Exosens

Exosens

EXENS.PA
Exosensundefined flagEuronext Paris
60.30
EUR
+0.35
- -
3.07BMarket Cap
Exosens
EXENS.PA
(Euronext Paris)

Recent

price

60.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
FRC
4.93
5.47
6.61
9.6
9.22
7.56
Revenue per Share
-0.52
-4.9
0.37
0.61
0.84
0.61
Basic EPS, GAAP
1.45
1.4
0.85
0.64
1.95
2.12
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
0.1
Dividend per Share
2.89
6.53
0.06
0.06
0.43
0.43
Book Value per Share
-11.04
-4.08
-4.53
-5.68
0.36
-0.27
Tangible Book Value per Share
30
30
30
30
51
51
Basic Weighted Avg Shares
150
166
201
292
468
383
Sales/Revenue/Turnover
20.44
19.48
16.41
18.72
21.83
21.02
Operating Margin (%)
8
11
19
28
35
40
Depreciation Expense
-16
-149
11
18
43
31
Net Income, GAAP
- -
- -
34.45
9.06
20.41
25.33
Effective Tax Rate (%)
-10.56
-89.65
5.59
6.31
9.12
8.01
Profit Margin (%)
60
59
72
83
207
166
Working Capital
429
204
243
304
8
14
LT Debt
97
172
183
204
413
446
Total Equity
- -
- -
5.27
10.09
16.77
13.59
Return on Invested Capital (%)
- -
- -
6.43
15.19
24.67
86.85
Return on Capital (%)
- -
-104.03
11.19
946.62
362.66
142.13
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
41.06%
8%
Free Cash Flow
- -
69.36%
8.7%
Net Income, GAAP
- -
180.33%
-28.1%
Sales/Revenue/Turnover
- -
23.88%
-18.11%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
58
67
- -
- -
292
2024
87
100
- -
- -
468
2025
- -
- -
- -
- -
383

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.01
- -
- -
- -
0.61
2024
0.07
- -
- -
- -
0.84
2025
- -
- -
- -
- -
0.61

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.1
Business
Exosens Technologies SA (EXENS.PA) is a leading provider of advanced optoelectronic solutions and image sensors for industrial, medical, scientific, and defense applications. The company develops and manufactures high-performance sensors, including CMOS image sensors, SWIR detectors, and X-ray imaging solutions; electron microscopy components such as cameras and detectors; and specialized systems for night vision, LiDAR, and hyperspectral imaging under brands like Lynred for infrared technologies and Teledyne e2v for scientific imaging. Exosens serves target markets including aerospace and defense, medical diagnostics, semiconductor inspection, and research institutions, with operations spanning Europe, North America, and Asia. Founded in 2023 through the acquisition and rebranding of Teledyne e2v by the European consortium Wisag, which includes investment from shareholder Partech, Exosens is headquartered in Paris, France, with key facilities in Grenoble, France; Chelmsford, UK; and global sites in the United States and Asia. In recent developments, Exosens completed its initial public offering on Euronext Paris in October 2024, raising approximately EUR 324 million to fuel expansion in AI-driven imaging and strategic growth initiatives; announced a strategic partnership with STMicroelectronics in 2025 to co-develop next-generation SPAD-based LiDAR sensors for automotive and robotics; and launched the new Emerald SWIR sensor platform in mid-2025, enhancing compact hyperspectral imaging for industrial sorting and defense reconnaissance.